Loading stock data...

Lactose (India) Limited

BSE: LACTOSE

BSE
97.16 1.14 (1.19%)

Prev Close

96.02

Open Price

96.99

Volume

793

Today Low / High

94.02 / 97.5

52 WK Low / High

84.27 / 136.7

Range

92 - 102

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 97.16, reflecting a change of 1.14 (1.18725%). The expected target range on the BSE is 92 - 102. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

24 Feb 96.90 -0.91%
23 Feb 97.00 0.03%
20 Feb 97.80 -0.84%
19 Feb 98.00 -0.20%
18 Feb 97.73 -1.32%
17 Feb 97.95 -0.22%
16 Feb 102.97 -7.47%
13 Feb 107.78 -4.74%
12 Feb 102.00 3.60%
11 Feb 102.03 -0.15%
10 Feb 101.52 0.83%
09 Feb 100.00 1.01%
06 Feb 102.00 -0.47%
05 Feb 102.00 0.00%
04 Feb 98.00 3.84%
03 Feb 99.89 -4.25%
02 Feb 98.89 -1.91%
01 Feb 96.20 -1.58%
30 Jan 99.00 -2.83%
29 Jan 100.75 -3.33%
28 Jan 100.50 -0.25%

Lactose (India) Limited Graph

Lactose (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Lactose (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 97.16, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 97.16 98.13 88.32 - 107.94
99.10 79.28 - 118.92
100.07 70.05 - 130.10
Bearish Scenario 97.16 96.19 86.57 - 105.81
95.22 76.17 - 114.26
94.25 65.97 - 122.52

Overview of Lactose (India) Limited

ISIN

INE058I01013

Industry

Medical - Pharmaceuticals

Vol.Avg

8,310

Market Cap

1,183,617,780

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

43.33

DCF

52

Financial Ratios Every Investor Needs

Stock Rating Details for LACTOSE

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 116.40 Cr 77.21 Cr 21.38 Cr 0.1837 0.00 Cr 1.83 Cr 11.57 Cr 5.16 Cr 4.10 18.41 Cr 0.0444
2024-03-31 113.89 Cr 88.95 Cr 24.94 Cr 0.2190 0.00 Cr 10.68 Cr 13.78 Cr 6.79 Cr 5.39 20.12 Cr 0.0596
2023-03-31 64.91 Cr 32.67 Cr 32.25 Cr 0.4968 0.00 Cr 1.19 Cr 6.77 Cr 1.21 Cr 0.96 12.10 Cr 0.0186
2022-03-31 45.94 Cr 15.67 Cr 29.44 Cr 0.6408 0.00 Cr 0.86 Cr 7.84 Cr 2.45 Cr 2.10 12.84 Cr 0.0534
2021-03-31 34.31 Cr 12.10 Cr 22.21 Cr 0.6472 0.00 Cr 0.78 Cr 2.35 Cr -2.48 Cr -2.40 6.54 Cr -0.0722

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 4.93 Cr 133.47 Cr 74.73 Cr 58.7396 Cr 56.83 Cr 51.90 Cr 24.55 Cr 62.51 Cr 0.00 Cr 0.29 Cr 0.00 Cr 44.8896 Cr
2024-03-31 1.53 Cr 100.74 Cr 53.64 Cr 47.0990 Cr 39.25 Cr 37.72 Cr 16.79 Cr 55.31 Cr 0.18 Cr 0.32 Cr -0.46 Cr 25.3985 Cr
2023-03-31 0.58 Cr 101.78 Cr 61.22 Cr 40.5609 Cr 38.96 Cr 38.38 Cr 22.78 Cr 56.06 Cr 0.03 Cr 0.93 Cr 0.00 Cr 26.5669 Cr
2022-03-31 1.92 Cr 90.22 Cr 50.94 Cr 39.2846 Cr 41.33 Cr 39.40 Cr 7.12 Cr 59.20 Cr 2.17 Cr 0.00 Cr 0.74 Cr 14.9106 Cr
2021-03-31 2.16 Cr 88.34 Cr 53.26 Cr 35.0894 Cr 46.15 Cr 43.98 Cr 8.32 Cr 63.02 Cr 1.06 Cr 0.82 Cr 0.68 Cr 11.6256 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -5.5816 Cr -15.5678 Cr 24.1000 Cr -19.9586 Cr 3.0772 Cr 4.9328 Cr -14.3770 Cr 5.1629 Cr 18.1188 Cr 0.0000 Cr -7.7598 Cr
2024-03-31 8.7754 Cr -2.0789 Cr -5.7475 Cr 6.5900 Cr 0.9490 Cr 1.5300 Cr -2.1854 Cr 9.6640 Cr -0.2962 Cr 0.0000 Cr 5.9863 Cr
2023-03-31 8.0572 Cr -1.0184 Cr -8.3811 Cr 6.4966 Cr -1.3424 Cr 0.5810 Cr -1.5606 Cr 1.4645 Cr -2.1086 Cr 0.0000 Cr -15.6610 Cr
2022-03-31 8.4667 Cr -0.5616 Cr -8.1436 Cr 7.1440 Cr -0.2385 Cr 1.9234 Cr -1.3227 Cr 3.1663 Cr -4.6360 Cr 0.0000 Cr 1.2035 Cr
2021-03-31 2.1650 Cr -6.1764 Cr 4.5237 Cr -3.3250 Cr 0.5122 Cr 2.1619 Cr -5.4900 Cr -3.2704 Cr 6.9862 Cr 0.0000 Cr 0.5865 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 36.77 Cr 31.53 Cr 5.24 Cr 0.1425 1.64 Cr 0.53 Cr 0.42 3.06 Cr 0.0144
2025-09-30 41.18 Cr 30.04 Cr 11.14 Cr 0.2705 3.81 Cr 2.16 Cr 1.71 5.63 Cr 0.0524
2025-06-30 39.58 Cr 29.45 Cr 10.13 Cr 0.2558 3.09 Cr 1.50 Cr 1.19 4.88 Cr 0.0379
2025-03-31 27.77 Cr 23.05 Cr 4.72 Cr 0.1699 2.02 Cr 0.64 Cr 0.50 3.78 Cr 0.0231
2024-12-31 28.72 Cr 20.21 Cr 8.51 Cr 0.2963 1.61 Cr 0.22 Cr 0.17 3.53 Cr 0.0076

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 3.63 Cr 2.24 Cr 5.87 Cr 23.76 Cr 19.24 Cr 56.10 Cr 67.13 Cr 137.81 Cr 75.42 Cr
2025-06-30 0.00 Cr 0.00 Cr 4.93 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -58.74 Cr
2025-03-31 4.93 Cr 0.00 Cr 4.93 Cr 23.24 Cr 24.55 Cr 57.33 Cr 62.51 Cr 133.47 Cr 74.73 Cr
2024-12-31 0.00 Cr 0.00 Cr 3.33 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -51.40 Cr
2024-09-30 2.86 Cr 0.58 Cr 3.44 Cr 20.48 Cr 18.36 Cr 46.75 Cr 54.52 Cr 112.99 Cr 61.59 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 2.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 2.27 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.80 ₹102,578,890,079.00 ₹242,213.00

Key Executives

Chairman & MD
Atul Surajmal Maheshwari

Gender: male

Year Born: 1965

Company Secretary & Compliance Officer
Ritesh A. Kumar Pandey

Gender: male

Year Born: 1986

Chief Financial Officer, Commercial Director & Whole Time Director
Sangita Atul Maheshwari

Gender: female

Year Born: 1967

Chief Operating Officer
Ranjit Kshirsagar

Gender: Not Specified

Year Born:

FAQs about Lactose (India) Limited

Who is the CEO of the company?

The CEO is Atul Surajmal Maheshwari.

What is the current market price of the stock?

The current price is ₹94.02.

What is the 52-week price range?

The range is ₹84.27-136.7.

What is the market capitalization of the company?

The market capitalization is ₹118.36 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 24.52.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Lactose (India) Limited (ISIN: INE058I01013) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹118.36 crores and an average daily volume of 8,310 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.